loading

Akero Therapeutics Inc Aktie (AKRO) Neueste Nachrichten

pulisher
03:55 AM

Can Akero Therapeutics Inc. (0K4) stock deliver strong annual returnsGold Moves & High Yield Equity Trading Tips - newser.com

03:55 AM
pulisher
03:14 AM

Will Akero Therapeutics Inc. (0K4) stock rise with strong economy2025 Volatility Report & Real-Time Chart Pattern Alerts - newser.com

03:14 AM
pulisher
02:07 AM

Heatmap analysis for Akero Therapeutics Inc. and competitorsIPO Watch & Fast Moving Market Watchlists - newser.com

02:07 AM
pulisher
01:30 AM

Is Akero Therapeutics Inc. stock a buy before product launchesWeekly Trade Review & Weekly Watchlist for Hot Stocks - newser.com

01:30 AM
pulisher
01:09 AM

Can Akero Therapeutics Inc. (0K4) stock beat analyst consensusEarnings Overview Summary & Consistent Growth Stock Picks - newser.com

01:09 AM
pulisher
12:36 PM

Will Akero Therapeutics Inc. stock gain from lower inflationTrade Risk Assessment & Precise Entry and Exit Recommendations - newser.com

12:36 PM
pulisher
Nov 02, 2025

Why Akero Therapeutics Stock Trounced the Market on Thursday - AOL.com

Nov 02, 2025
pulisher
Nov 02, 2025

Using RSI to spot recovery in Akero Therapeutics Inc.Gap Up & Expert Curated Trade Setups - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Chart based analysis of Akero Therapeutics Inc. trendsWeekly Market Outlook & Entry Point Confirmation Signals - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Is Akero Therapeutics Inc. stock a top pick in earnings seasonPortfolio Risk Summary & Technical Entry and Exit Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

How high can Akero Therapeutics Inc. stock go2025 AllTime Highs & Low Drawdown Investment Ideas - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Jennison Associates LLC Grows Stock Position in Akero Therapeutics, Inc. $AKRO - MarketBeat

Nov 02, 2025
pulisher
Nov 02, 2025

Will Akero Therapeutics Inc. stock reach Wall Street targetsAnalyst Downgrade & High Conviction Buy Zone Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Y Intercept Hong Kong Ltd Takes Position in Akero Therapeutics, Inc. $AKRO - MarketBeat

Nov 02, 2025
pulisher
Nov 02, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) Short Interest Update - MarketBeat

Nov 02, 2025
pulisher
Nov 01, 2025

Will Akero Therapeutics Inc. outperform the market2025 Support & Resistance & Fast Entry Momentum Alerts - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Fatty liver disease companies' multibillion-dollar deals mean fatter walletsSan Francisco Business Times - The Business Journals

Oct 31, 2025
pulisher
Oct 31, 2025

Can volume confirm reversal in Akero Therapeutics Inc.2025 Fundamental Recap & Daily Stock Momentum Reports - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Is Akero Therapeutics Inc. trending in predictive chart modelsJuly 2025 Levels & Weekly High Return Opportunities - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Emerald Mutual Fund Advisers Trust Has $7.27 Million Stock Position in Akero Therapeutics, Inc. $AKRO - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

Is Akero Therapeutics Inc. (0K4) stock included in top ETFsJuly 2025 Trends & Stepwise Trade Signal Guides - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Can Akero Therapeutics Inc. (0K4) stock surprise with quarterly resultsChart Signals & Entry Point Confirmation Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Why Akero Therapeutics Inc. stock is recommended by analystsTrade Analysis Report & Free Low Drawdown Momentum Trade Ideas - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

Altimmune: Competitor Buyouts Plus Regulatory And Clinical Progress (NASDAQ:ALT) - Seeking Alpha

Oct 30, 2025
pulisher
Oct 30, 2025

Akero Stock Hits Over 18-Month High On MASH Trial Data: Citi Lauds ‘Best-Case Scenario,’ Retail Exuberant - MSN

Oct 30, 2025
pulisher
Oct 29, 2025

Berger Montague PC Investigates Akero Therapeutics, Inc. and Its Board of Directors for Breach of Fiduciary Duties and Violations of Federal Securities Laws (NASDAQ: AKRO) - Lelezard

Oct 29, 2025
pulisher
Oct 29, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

Oct 29, 2025
$37.33
price down icon 0.21%
$92.90
price down icon 0.29%
$28.82
price up icon 0.74%
$104.39
price up icon 0.46%
biotechnology ONC
$312.52
price up icon 0.95%
$182.24
price down icon 3.63%
Kapitalisierung:     |  Volumen (24h):